Chemotherapeutic induction of egr-1 promoter activity

作者: Ralph R. Weichselbaum , Helena Mauceri , Mitchell Posner , James Park , Donald W. Kufe

DOI:

关键词:

摘要: The present invention provides for improved therapeutic regimens treating benign hyperproliferative diseases and cancers. Egr-1 promoter, long known to be radiation-responsive, has now been shown inducible DNA damaging chemical agents, many of which themselves are used in therapies. Thus, the advantages combination a an expression vector containing gene driven by promoter.

参考文章(86)
Ellen S. Vitetta, Victor F. Ghetie, Jonathan W. Uhr, Methods and compositions concerning homogenous immunotoxin preparations ,(1993)
C Myers, The role of iron in doxorubicin-induced cardiomyopathy. Seminars in Oncology. ,vol. 25, pp. 10- 14 ,(1998)
禎尚 並木, 節子 國元, 達裕 常喜, 典也 大野, 俊昭 阿部, 真理子 中村, 清嗣 吉田, MODIFICATION OF DOXORUBICIN MOLECULE ENHANCED THE EARLY GROWTH RESPONSE GENE 1 PROMOTER ACTIVITY Jikeikai medical journal. ,vol. 43, pp. 1- 7 ,(1996)
J. William Harbour, Douglas C. Dean, Rb function in cell-cycle regulation and apoptosis Nature Cell Biology. ,vol. 2, ,(2000) , 10.1038/35008695
Thomas D. Palella, Myron Levine, William N. Kelley, Viral-mediated gene transfer system ,(1994)
Arthur J. Zaug, Thomas R. Cech, Michael D. Been, RNA Ribozyme which cleaves substrate RNA without formation of a convalent bond ,(1992)